Biogen Inc vs LyondellBasell Industries NV — how do they compare? Biogen Inc trades at $204 (market cap $30.13B), while LyondellBasell Industries NV trades at $63.73 (market cap $20.67B). The key difference: Biogen Inc is the larger of the two by market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | LYB | |
|---|---|---|
Market Cap | $30.13B | $20.67B |
Sector | Health | Basic Materials |
52-Week High | $216.63 | $82.38 |
52-Week Low | $128.93 | $42.28 |
Enterprise Value | $37.20B | $32.26B |
Dividend Yield | — | 6.44% |
Trailing returns across standard periods
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →